10,724
Total Claims
$2.4M
Drug Cost
1,199
Beneficiaries
$1,997
Cost/Patient
Peer Comparison vs. 5,101 Rheumatology providers
+19%
Opioid rate vs peers
4.8% vs 4.1% avg
-67%
Cost per patient vs peers
$1,997 vs $6,039 avg
Opioid Prescribing
4.8%
Opioid Rate
516
Opioid Claims
$13K
Opioid Cost
5.6%
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 10,203 claims · $250K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Etanercept | 93 | $658K |
| Upadacitinib | 83 | $511K |
| Adalimumab | 52 | $367K |
| Abatacept | 18 | $96K |
| Denosumab | 53 | $85K |
| Etanercept | 11 | $76K |
| Tocilizumab | 11 | $51K |
| Pregabalin | 1,002 | $43K |
| Gabapentin | 2,044 | $35K |
| Abaloparatide | 13 | $33K |
| Romosozumab-Aqqg | 11 | $26K |
| Celecoxib | 232 | $17K |
| Diclofenac Potassium | 167 | $14K |
| Etodolac | 213 | $13K |
| Tizanidine Hcl | 1,227 | $13K |
Prescribing Profile
52
Unique Drugs
$733K
Patient Profile
69
Avg Age
79%
Female
1.65
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About